A once-weekly oral methadone for maintenance therapy for opioid use disorder — Patrick Boen (LYNDRA THERAPEUTICS, INC.)
Methadone is an FDA-approved medication-assisted therapy (MAT) for opioid use disorder (OUD). Methadone maintenance therapy has been shown to facilitate recovery and prevent deaths. In the US methadon
| Project title | A once-weekly oral methadone for maintenance therapy for opioid use disorder |
|---|---|
| Project number | 4UH3DA050310-02 |
| PI name | Patrick Boen |
| Institution | LYNDRA THERAPEUTICS, INC. |
| Funding mechanism | UH3 |
| Agency | NIDA |
| Award amount | $11.70M |
| Fiscal year | 2021 |
| Project start | 2019-09-30T00:00:00 |
| Project end | 2025-04-30T00:00:00 |
| Abstract | Methadone is an FDA-approved medication-assisted therapy (MAT) for opioid use disorder (OUD). Methadone maintenance therapy has been shown to facilitate recovery and prevent deaths. In the US methadon |
| Key terms | <AD dementia><AIDS Virus><Access to Care><Acquired Immune Deficiency Syndrome Virus><Acquired Immuno |
$799/mo
Try GrantRadar →